Peter J Schwartz

41PUBLICATIONS
324CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Circuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 22, 2026
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

|Aug 28, 2026
Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.

|May 13, 2026
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

|May 11, 2026
Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

|May 06, 2026
An organic artificial cardiomyocyte.

|Mar 18, 2026
CALM1, CALM2, and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy.

Steffan Noe Niikanoff Christiansen, Stine Bøttcher Jacobsen, Jeppe Dyrberg Andersen

Pageof 7

Frequent Collaborators

18 joint publications

Lia Crotti

12 joint publications

Federica Dagradi

10 joint publications

Carla Spazzolini

9 joint publications

Luca Sala